Search results: Sage Journals

Restricted accessArticle commentaryFirst published June, 2018

The Electronic Health Record Foundation for Pharmaceutical Management

Richard G. Stefanacci, Scott Guerin, Tim Van Aken

Population Health Management

Restricted accessOtherFirst published April, 2001

Distribution of Off-Label Information by Pharmaceutical Manufacturers? *

Meryl Weiss Robinson, Barry Grobman, David Graves

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published August, 2006

Human Tissue for In Vitro Research as an Alternative to Animal Experiments: A Charitable “Honest Broker” Model to Fulfil Ethical and Legal Regulations and to Protect Research Participants

Wolfgang E. Thasler, Thilo Schlott, Arno Kalkuhl [...]

Alternatives to Laboratory Animals

Restricted accessResearch articleFirst published June, 2008

Wisconsin Alumni Research Foundation v. Xenon Pharmaceuticals,Inc. (2007-1026,-1033)

Biotechnology Law Report

Restricted accessOtherFirst published February, 2010

Wisconsin Alumni Research Foundation v. Xenon Pharmaceuticals,Inc. (Nos. 08-1351 & 06-3901)

Biotechnology Law Report

Restricted accessOtherFirst published December, 2003

Elan Pharmaceuticals,Inc. and Athena Neurosciences,Inc.,Plaintiffs-Appellants,v. Mayo Foundation for Medical Education and Research,Defendant-Appellee (00-1467)

Biotechnology Law Report

Restricted accessResearch articleFirst published September, 2018

Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics

Aaron Mitchell, Benyam Muluneh, Rachana Patel [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published January, 1992

Strategic Planning in the US Pharmaceutical Industry: An Introduction

Gerard W. Wood, Ashok K. Gumbhir, Johnny L. Anderson [...]

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published December, 2009

Brief of Washington Legal Foundation as Amicus Curiae in Support of Defendant-Appellant Supporting Reversal: Ariad Pharmaceuticals,Inc. et al. v. Eli Lilly and Company

Biotechnology Law Report

Restricted accessResearch articleFirst published October, 2006

The Regents of the University of California v. University of Iowa Research Foundation and Coley Pharmaceutical Group,Inc.,and The United States of America (as Represented by the Department of Health and Human Services) (Interference No. 105,171) (05-1374)

Biotechnology Law Report

Restricted accessArticle commentaryFirst published June, 2018

The Electronic Health Record Foundation for Pharmaceutical Management

Richard G. Stefanacci, Scott Guerin, Tim Van Aken

Population Health Management

Restricted accessOtherFirst published April, 2001

Distribution of Off-Label Information by Pharmaceutical Manufacturers? *

Meryl Weiss Robinson, Barry Grobman, David Graves

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published August, 2006

Human Tissue for In Vitro Research as an Alternative to Animal Experiments: A Charitable “Honest Broker” Model to Fulfil Ethical and Legal Regulations and to Protect Research Participants

Wolfgang E. Thasler, Thilo Schlott, Arno Kalkuhl [...]

Alternatives to Laboratory Animals

Restricted accessResearch articleFirst published June, 2008

Wisconsin Alumni Research Foundation v. Xenon Pharmaceuticals,Inc. (2007-1026,-1033)

Biotechnology Law Report

Restricted accessOtherFirst published February, 2010

Wisconsin Alumni Research Foundation v. Xenon Pharmaceuticals,Inc. (Nos. 08-1351 & 06-3901)

Biotechnology Law Report

Restricted accessOtherFirst published December, 2003

Elan Pharmaceuticals,Inc. and Athena Neurosciences,Inc.,Plaintiffs-Appellants,v. Mayo Foundation for Medical Education and Research,Defendant-Appellee (00-1467)

Biotechnology Law Report

Restricted accessResearch articleFirst published September, 2018

Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics

Aaron Mitchell, Benyam Muluneh, Rachana Patel [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published January, 1992

Strategic Planning in the US Pharmaceutical Industry: An Introduction

Gerard W. Wood, Ashok K. Gumbhir, Johnny L. Anderson [...]

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published December, 2009

Brief of Washington Legal Foundation as Amicus Curiae in Support of Defendant-Appellant Supporting Reversal: Ariad Pharmaceuticals,Inc. et al. v. Eli Lilly and Company

Biotechnology Law Report

Restricted accessResearch articleFirst published October, 2006

The Regents of the University of California v. University of Iowa Research Foundation and Coley Pharmaceutical Group,Inc.,and The United States of America (as Represented by the Department of Health and Human Services) (Interference No. 105,171) (05-1374)

Biotechnology Law Report